Hierarchical image pyramid transformer framework for automated breast cancer molecular subtyping using tissue microarrays
The Journal of Pathology · 2026-04 · 268 (4) · 460-476
DOI: 10.1002/path.70028 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology, online erschienen am 26.01.2026. Verfasst von Baizhou Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, PR China. Hauptthemen laut MEDLINE: Breast Neoplasms, Tissue Array Analysis, Biomarkers, Tumor, Deep Learning. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
The heterogeneity of breast cancer at molecular and histological levels poses significant challenges for precise diagnosis and treatment. Current molecular subtyping, crucial for guiding personalized therapy, relies on immunohistochemistry, which is often limited by intratumoral heterogeneity and potential sampling bias. While deep learning shows promise in digital pathology, existing models face computational and technical hurdles in capturing multiscale morphological features and long‐range dependencies from high‐resolution images, particularly in the context of tissue microarrays (TMAs). To address this, we developed and validated the pathomics breast cancer hierarchical image pyramid transformer (PBC‐HIPT), a novel deep learning framework designed for automated molecular subtyping from standard H&E‐stained images. The PBC‐HIPT model utilizes a multilevel transformer‐based architecture to hierarchically aggregate histopathological features from the cellular to the tissue scale, enabling a comprehensive analysis. We trained and validated the model on a multi‐institutional cohort comprising 252 TMA cases and 46 independent whole‐slide images (WSIs), assessing its performance via five‐fold cross‐validation on three‐, four‐, and five‐class molecular subtyping tasks, as well as key biomarker [estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), Ki‐67] prediction, comparing it against several established multiple instance learning methods. PBC‐HIPT demonstrated superior performance, achieving a mean accuracy of 84.3% and a mean area under the curve (AUC) of 0.91 in the clinically critical three‐class subtyping task (luminal, HER2‐enriched, triple‐negative breast cancer), significantly outperforming baseline models. The framework excelled in biomarker prediction, attaining accuracies of 91.8% (AUC: 0.97) for ER status and 92.0% (AUC: 0.96) for PR status. It also achieved an accuracy of 73.8% (AUC: 0.81) for Ki‐67 proliferation status and 84.6% (AUC: 0.85) for binary HER2 status classification. While the model showed robust intramodality generalization on TMAs (ER AUC > 0.96), its performance dropped in WSI cross‐modality validation. In conclusion, the PBC‐HIPT model provides a robust, automated solution for accurate molecular subtyping and biomarker assessment from H&E‐stained TMAs. © 2026 The Pathological Society of Great Britain and Ireland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, PR China.
- Department of Pathology, Fourth Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, PR China.
- School of Information Science and Technology, Northwest University, Xi'an, PR China.
- Department of Breast Surgery, Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, PR China.
- Artificial Intelligence and Biomedical Images Analysis Lab, School of Engineering, Westlake University, Zhejiang, PR China.
- Key Laboratory of Tumor Microenvironment and Immune Therapy of Zhejiang Province, Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, PR China.
ORCID-Profile: Wuzhen Chen
Förderung
- Natural Science Foundation of Zhejiang Province
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Medical Science and Technology Project of Zhejiang Province
Zitieren
APA
Li, B., Zhong, Y., Xing, Z., Zhou, J., Li, H., Yang, L., & Chen, W. (2026). Hierarchical image pyramid transformer framework for automated breast cancer molecular subtyping using tissue microarrays. The Journal of Pathology, 268(4), 460-476. https://doi.org/10.1002/path.70028
Vancouver
Li B, Zhong Y, Xing Z, Zhou J, Li H, Yang L, et al. Hierarchical image pyramid transformer framework for automated breast cancer molecular subtyping using tissue microarrays. The Journal of Pathology. 2026;268(4):460-476. doi:10.1002/path.70028
BibTeX
@article{Li2026,
author = {Li, Baizhou and Zhong, Yuting and Xing, Zehang and Zhou, Jiaojiao and Li, Hansheng and Yang, Lin and Chen, Wuzhen},
title = {Hierarchical image pyramid transformer framework for automated breast cancer molecular subtyping using tissue microarrays},
journal = {The Journal of Pathology},
year = {2026},
volume = {268},
number = {4},
pages = {460--476},
doi = {10.1002/path.70028}
}
EUVIMED